Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shukai Yuan
Observed names:
S. Yuan,
S.S. Yuan,
Shu-Kai Yuan
Institutions:
Tianjin Medical University Cancer Institute and Hospital,
Tianjin Medical University
Observed institutions:
Southwest University,
Tianjin Medical University Cancer Institute and Hospital,
China Agricultural University,
Tianjin Medical University
ORCID:
0000-0003-0354-5113
Observed ORCID:
0000-0003-0354-5113
OpenAlex ID:
A5005013316
MiR-31 promotes mammary stem cell expansion and breast tumorigenesis by suppressing Wnt signaling antagonists
2017
·
Cong Lv
, Fengyin Li
, et al.
·
Nature Communications
·
196
PDF
MiR-31 Mediates Inflammatory Signaling to Promote Re-Epithelialization during Skin Wound Healing
2018
·
Jianyun Shi
, Xianghui Ma
, et al.
·
Journal of Investigative Dermatology
·
129
Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors
2022
·
Peitao Zhang
, Haixia Guan
, et al.
·
Nature Communications
·
94
Post-transcriptional Regulation of Keratinocyte Progenitor Cell Expansion, Differentiation and Hair Follicle Regression by miR-22
2015
·
Shukai Yuan
, Feifei Li
, et al.
·
PLoS Genetics
·
63
PDF
miR-22 promotes stem cell traits via activating Wnt/β-catenin signaling in cutaneous squamous cell carcinoma
2021
·
Shukai Yuan
, Peitao Zhang
, et al.
·
Oncogene
·
54
PDF
Msi1 promotes breast cancer metastasis by regulating invadopodia-mediated extracellular matrix degradation via the Timp3–Mmp9 pathway
2021
·
Xueyun Bi
, Pengbo Lou
, et al.
·
Oncogene
·
40
Synthesis, characterization and DNA interaction of copper (II) complexes with Schiff base ligands derived from 2-pyridinecarboxaldehyde and polyamines
2010
·
Xin-Bin Yang
, Yu Huang
, et al.
·
Inorganic Chemistry Communications
·
35
TBX3 promotes proliferation of papillary thyroid carcinoma cells through facilitating PRC2-mediated p57KIP2 repression
2018
·
Xiaomeng Li
, Xianhui Ruan
, et al.
·
Oncogene
·
29
USP9X integrates TGF-β and hypoxia signalings to promote ovarian cancer chemoresistance via HIF-2α-maintained stemness
2025
·
Zhenlei Zhang
, Xiujie Yu
, et al.
·
Cell Death and Disease
·
27
PDF
Prognostic Value and Dynamics of Antithyroglobulin Antibodies for Differentiated Thyroid Carcinoma
2020
·
Danyang Sun
, Xiangqian Zheng
, et al.
·
Biomarkers in Medicine
·
19
502 Pembrolizumab (MK-3475) for patients (pts) with advanced colorectal carcinoma (CRC): Preliminary results from KEYNOTE-028
2015
·
B.H. O'Neil
, J. Wallmark
, et al.
·
European Journal of Cancer
·
18
500 Pembrolizumab (MK-3475) for PD-L1-positive squamous cell carcinoma (SCC) of the anal canal: Preliminary safety and efficacy results from KEYNOTE-028
2015
·
P.A. Ott
, S.A. Piha-Paul
, et al.
·
European Journal of Cancer
·
17
Targeting miR‐31 represses tumourigenesis and dedifferentiation of BRAF V600E ‐associated thyroid carcinoma
2024
·
Peitao Zhang
, Lizhao Guan
, et al.
·
Clinical and Translational Medicine
·
15
miR-22 promotes immunosuppression via activating JAK/STAT3 signaling in cutaneous squamous cell carcinoma
2023
·
Shukai Yuan
, Tong Zhu
, et al.
·
Carcinogenesis
·
12
2801 Antitumor activity and safety of pembrolizumab in patients with PD-L1-positive nasopharyngeal carcinoma: Interim results from a hase 1b study
2015
·
C. Hsu
, S.H. Lee
, et al.
·
European Journal of Cancer
·
8
Cysteine Dioxygenase Regulates the Epithelial Morphogenesis of Mammary Gland via Cysteine Sulfinic Acid
2019
·
Jianjun Zhao
, Yuzhu Han
, et al.
·
iScience
·
7
PDF
Author Correction: MiR-31 promotes mammary stem cell expansion and breast tumorigenesis by suppressing Wnt signaling antagonists
2020
·
Cong Lv
, Fengyin Li
, et al.
·
Nature Communications
·
4
PDF
Author Correction: Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors
2022
·
Peitao Zhang
, Haixia Guan
, et al.
·
Nature Communications
·
3
PDF
Correction: miR-22 promotes stem cell traits via activating Wnt/β-catenin signaling in cutaneous squamous cell carcinoma
2023
·
Shukai Yuan
, Peitao Zhang
, et al.
·
Oncogene
PDF
Correction: miR-22 promotes stem cell traits via activating Wnt/β-catenin signaling in cutaneous squamous cell carcinoma
2022
·
Shukai Yuan
, Peitao Zhang
, et al.
·
Oncogene
PDF
A novel therapeutic strategy for effective elimination of glioblastoma stem cells using biochemical mechanism-based drug combinations.
2011
·
S. Yuan
, F. Wang
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
21
Citation count:
770
H-index:
13
I10-index:
14
Year
Topic
Type